Table 1.

Human HSCs generate significant numbers of hepatocytes in a noninjury fetal model


Phenotype

Source

Cell dose

No. animals

Time after transplantation

Human hepatocytes, %
CD34+Lin-  BM   5.0 × 106  2   3 wk   1.8 ± 0.1  
      3.0 ± 0.05  
CD34+Lin-  BM   1.3 × 105  2   5 wk   2.0 ± 0.08  
      3.2 ± 0.1  
CD34+Lin-  BM   6.7 × 104  2   4 mo   5.5 ± 0.2  
      10 ± 0.8  
CD34+Lin-  CB   3.8 × 105  2   2 mo   1.0 ± 0.01  
      2.0 ± 0.05  
CD34-Lin-  CB   1.1 × 106  1   2 mo   2.0 ± 1.0  
CD34-Lin-
 
CB
 
5.0 × 105
 
1
 
11 mo
 
17.0 ± 2.0
 

Phenotype

Source

Cell dose

No. animals

Time after transplantation

Human hepatocytes, %
CD34+Lin-  BM   5.0 × 106  2   3 wk   1.8 ± 0.1  
      3.0 ± 0.05  
CD34+Lin-  BM   1.3 × 105  2   5 wk   2.0 ± 0.08  
      3.2 ± 0.1  
CD34+Lin-  BM   6.7 × 104  2   4 mo   5.5 ± 0.2  
      10 ± 0.8  
CD34+Lin-  CB   3.8 × 105  2   2 mo   1.0 ± 0.01  
      2.0 ± 0.05  
CD34-Lin-  CB   1.1 × 106  1   2 mo   2.0 ± 1.0  
CD34-Lin-
 
CB
 
5.0 × 105
 
1
 
11 mo
 
17.0 ± 2.0
 

Human HSCs were isolated by cell sorting and were transplanted intraperitoneally into preimmune sheep fetuses at 55 to 65 days of gestation. Values for human hepatocytes represent the average ± SD of hepatocytes found in each of the animals analyzed at a given time point.

or Create an Account

Close Modal
Close Modal